What's new

1. 54 minutes ago
   News Read press release about Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 ↗

   Faeth Therapeutics, Inc.
2. 54 minutes ago
   News Read press release about Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors ↗

   Faeth Therapeutics, Inc.
3. 3 hours ago
   News CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases ↗

   Alentis Therapeutics AG
4. 6 hours ago
   News How to Verify Your 1win Casino Code Account – Step‑by‑Step Guide ↗

   Palobiofarma SL
5. 2 days ago
   Readout Primary readout date moved: Pembrolizumab

   2026-11-06 → 2027-02-12
6. 2 days ago
   Trial Trial status changed: Patritumab Deruxtecan

   Recruiting → Active not recruiting
7. 2 days ago
   Trial Trial status changed: Cannabidiol (Epidiolex)

   Not yet recruiting → Recruiting
8. 2 days ago
   Readout Primary readout date moved: Evolocumab

   2026-09-03 → 2026-09-02
9. 2 days ago
   Readout Primary readout date moved: Rilpivirine

   2026-01-30 → 2027-06-30
10. 2 days ago
    Trial New registered study: survodutide

    3 · NOT_YET_RECRUITING
11. 2 days ago
    Trial New registered study: zenagamtide

    1 · NOT_YET_RECRUITING
12. 2 days ago
    Trial New registered study: semaglutide

    1 · NOT_YET_RECRUITING

Research adds SEC filings, financials, earnings and ownership updates.